Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Other Operating Expenses (2016 - 2025)

Apyx Medical's Other Operating Expenses history spans 11 years, with the latest figure at $16000.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 109.82% year-over-year to $16000.0; the TTM value through Dec 2025 reached $9.3 million, up 5885.71%, while the annual FY2025 figure was $92000.0, 157.14% up from the prior year.
  • Other Operating Expenses reached $16000.0 in Q4 2025 per APYX's latest filing, down from $76000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.7 million in Q2 2025 to a low of -$551000.0 in Q4 2022.
  • Average Other Operating Expenses over 5 years is $637111.1, with a median of -$3000.0 recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: tumbled 320.0% in 2024, then skyrocketed 469400.0% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at -$185000.0 in 2021, then plummeted by 197.84% to -$551000.0 in 2022, then surged by 588.57% to $2.7 million in 2023, then tumbled by 106.05% to -$163000.0 in 2024, then skyrocketed by 109.82% to $16000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Other Operating Expenses are $16000.0 (Q4 2025), $76000.0 (Q3 2025), and $4.7 million (Q2 2025).